SOD2 and non-small cell lung carcinoma: A phase I study of DOTAP: Cholesterol-Fus1 Liposome Complex (DOTAP: Chol-fus1) (NCT00059605), a phase I-II study, DOTAP: Chol-TUSC2 (NCT01455389) combination with erlotinib, dexamethasone, and diphenhydramine, a phase I–II study of Manganese Superoxide Dismutase (MnSOD) Plasmid Liposome (NCT00618917) in combination with carboplatin, paclitaxel, and radiotherapy, and a phase I study of lurtotecan liposome (NCT00006036) combined with cisplatin are some of the examples of ongoing clinical trials exploring liposomal therapies for NSCLC.